Science Explorer Interactive view Map
Company · Strel'na · Russia

BIOCAD (Russia)

Research works
105
▲ 287% vs 2013–17
Citations
370
3.5 per fractional work
Top-10% rate
5.3%
record average 16.5%
Open access
64%
world 28%

Not ranked overall: BIOCAD (Russia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.85× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.44× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 8.49× its world share, 3 worksImmunology and Micro…Neuroscience: 1.72× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.13× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 2.58× its world share, 0 worksChemical EngineeringChemistry: 1.29× its world share, 1 worksChemistryComputer Science: 0.66× its world share, 2 worksComputer ScienceEngineering: 0.50× its world share, 3 worksEngineeringEnvironmental Science: 0.14× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.40× its world share, 0 worksMaterials ScienceMathematics: 2.68× its world share, 1 worksMathematicsHealth Professions: 0.17× its world share, 0 worksHealth ProfessionsMedicine: 2.22× its world share, 16 worksMedicineNursing: 0.46× its world share, 0 worksNursingVeterinary: 9.95× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.42× its world share, 0 worksBusiness, Management…Decision Sciences: 1.63× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 1.05× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.07× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Veterinary, 9.9×. Every wedge is a field page.

Who are the top researchers at BIOCAD (Russia)?

Ranked on the composite score, Roman Ivanov lead among researchers whose main affiliation is BIOCAD (Russia).

  1. 1 Roman Ivanov Russia · #717,198 worldwide 20 citations · 21 works
All ranked researchers at BIOCAD (Russia)

Which keywords describe research at BIOCAD (Russia)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Autoantibodies, Cancer Immunotherapy, Biopharmaceuticals and Immunogenicity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Monoclonal Antibodies3▲ 100×3 topics
  2. Epidemiology2▲ 1.62×10 topics
  3. Therapeutic Antibodies2▲ 85×2 topics
  4. Cancer2▲ 3.9×8 topics
  5. Antibody Engineering2▲ 87×1 topic
  6. Fc Receptors2▲ 87×1 topic
  7. Immunotherapy2▲ 6.3×6 topics
  8. Inflammation2▲ 2.3×4 topics
  9. Autoantibodies2▲ 19×4 topics
  10. Cancer Immunotherapy2▲ 28×3 topics
  11. Biopharmaceuticals2▲ 81×2 topics
  12. Clinical Outcomes2▲ 19×2 topics
  13. E-Learning2▲ 4.0×3 topics
  14. Educational Technology2▲ 3.4×3 topics
  15. Immunogenicity2▲ 97×2 topics
  16. Cytokines1▲ 12×2 topics
  17. Biological Therapy1▲ 60×1 topic
  18. Chemotherapy1▲ 4.5×9 topics
  19. Deep Learning1◆ 0.94×4 topics
  20. Ethical Considerations1▲ 9.3×2 topics
  21. Public Health1▲ 2.2×2 topics
  22. Rheumatoid Arthritis1▲ 35×1 topic
  23. Bioanalytical Methods1▲ 149×1 topic
  24. Biosimilars1▲ 149×1 topic
  25. Cancer Progression1▲ 16×3 topics
  26. Immune System1▲ 12×3 topics
  27. Lymphoma1▲ 18×2 topics
  28. Machine Learning1◆ 0.94×5 topics
  29. Pathogenesis1▲ 5.9×4 topics
  30. Tumor Regression1▲ 27×2 topics
  31. Biomedical Science1▲ 140×1 topic
  32. CAR T Cells1▲ 38×1 topic
  33. Chimeric Antigen Receptor1▲ 38×1 topic
  34. Health Research1▲ 26×1 topic
  35. SMN11▲ 128×1 topic
  36. Spinal Muscular Atrophy1▲ 128×1 topic

Which research topics does BIOCAD (Russia) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Rheumatoid Arthritis Research and Therapies, Biosimilars and Bioanalytical Methods and Neurogenetic and Muscular Disorders Research.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  2. 2 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  3. 3 Biosimilars and Bioanalytical Methods Immunology 1 works
  4. 4 Neurogenetic and Muscular Disorders Research Genetics 1 works
  5. 5 CAR-T cell therapy research Oncology 1 works
  6. 6 Science, Research, and Medicine Reproductive Medicine 1 works
  7. 7 Spondyloarthritis Studies and Treatments Rheumatology 1 works
  8. 8 Educational Innovations and Challenges Information Systems 1 works
  9. 9 RNA modifications and cancer Molecular Biology 1 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.3%not open35.7%

World: 28% of research is openly available.

with international co-authors11.4%domestic only88.6%

World: 19% is written across borders.

How has BIOCAD (Russia)'s research output changed?

Output in 2018–2022 was 287% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.